Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization

Li He1, Jamie Fong, Mark von Zastrow

  • 1Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, CA 94608, USA.

Cell
|February 8, 2002
PubMed

Insights

Morphine tolerance, a challenge in chronic pain management, can be reduced. Combining morphine with DAMGO facilitates mu opioid receptor (MOR) endocytosis, significantly decreasing analgesic tolerance in rats.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Management

Background:

  • Chronic pain treatment is limited by morphine tolerance.
  • Morphine activates mu opioid receptors (MOR) without promoting desensitization or endocytosis.
  • Developing strategies to overcome analgesic tolerance is crucial for effective pain management.

Purpose of the Study:

  • To investigate if DAMGO can facilitate MOR endocytosis induced by morphine.
  • To determine if co-administration of morphine and DAMGO reduces analgesic tolerance.
  • To explore the potential of MOR endocytosis as a therapeutic target for chronic pain.

Main Methods:

  • Utilized [D-Ala(2)-MePhe(4)-Gly(5)-ol] enkephalin (DAMGO) to target MOR.
  • Administered morphine and DAMGO to rats for chronic treatment.
  • Assessed analgesic tolerance by comparing drug efficacy over time.

Main Results:

  • DAMGO facilitated morphine-induced MOR endocytosis.
  • Rats treated with both morphine and DAMGO exhibited reduced analgesic tolerance compared to morphine-only treatment.
  • MOR endocytosis was shown to mitigate the development of analgesic tolerance.

Conclusions:

  • MOR endocytosis is a viable mechanism to reduce opioid analgesic tolerance.
  • Co-administration of MOR-internalizing agents with morphine offers a potential strategy for improved chronic pain therapy.
  • This research paves the way for developing novel opioid analogs with sustained analgesic efficacy.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K